These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6835711)

  • 21. [Possibilities to increase the efficacy of growth hormone therapy in Turner syndrome].
    Ságodi L; Sólyom E
    Orv Hetil; 1997 Jun; 138(23):1501-5. PubMed ID: 9254366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Growth in children with 45XO Turner's syndrome.
    Brook CG
    Arch Dis Child; 1974 Oct; 49(10):821. PubMed ID: 4429375
    [No Abstract]   [Full Text] [Related]  

  • 23. Experience in management of diminished growth in adolescent Turner's syndrome patients.
    Tuschy U
    Padiatr Grenzgeb; 1992; 31(2):123-30. PubMed ID: 1305284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone maturation in girls with Turner's syndrome.
    Even L; Bronstein V; Hochberg Z
    Eur J Endocrinol; 1998 Jan; 138(1):59-62. PubMed ID: 9461317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of girls with Turner's syndrome with growth hormone and estrogen--1-year experiences].
    Naeraa RW; Nielsen J; Kastrup KW
    Ugeskr Laeger; 1992 Jun; 154(25):1773-8. PubMed ID: 1632017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Turner's syndrome.
    Taback SP; Deal C; Van Vliet G
    N Engl J Med; 1997 May; 336(21):1527; author reply 1527-8. PubMed ID: 9157285
    [No Abstract]   [Full Text] [Related]  

  • 27. Near normalization of final height with adapted doses of growth hormone in Turner's syndrome.
    Carel JC; Mathivon L; Gendrel C; Ducret JP; Chaussain JL
    J Clin Endocrinol Metab; 1998 May; 83(5):1462-6. PubMed ID: 9589639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome.
    Reiter EO; Blethen SL; Baptista J; Price L
    J Clin Endocrinol Metab; 2001 May; 86(5):1936-41. PubMed ID: 11344188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):760-1. PubMed ID: 11155102
    [No Abstract]   [Full Text] [Related]  

  • 30. [Growth hormone for Turner's syndrome].
    Fishman A; Hochberg Z
    Harefuah; 1991 Nov; 121(9):281-6. PubMed ID: 1800273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Growth effect of oxandrolone in patients with Turner's syndrome (author's transl)].
    Armendares S; Ramos RM; Navarrete C; Salamanca F
    Rev Invest Clin; 1978; 30(4):343-50. PubMed ID: 362499
    [No Abstract]   [Full Text] [Related]  

  • 32. Skeletal demineralization in Turner's syndrome.
    Shore RM; Chesney RW; Mazess RB; Rose PG; Bargman GJ
    Calcif Tissue Int; 1982; 34(6):519-22. PubMed ID: 6819070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal changes during development in Turner's syndrome.
    Van Vliet G
    Acta Paediatr Scand Suppl; 1988; 343():31-7. PubMed ID: 3057806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous growth in Turner's syndrome.
    Tuschy U
    Padiatr Grenzgeb; 1990; 29(5):419-23. PubMed ID: 2234982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.
    Lu PW; Cowell CT; Jimenez M; Simpson JM; Silink M
    Arch Dis Child; 1991 Oct; 66(10):1184-90. PubMed ID: 1953000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of growth retardation with androgens in Turner's syndrome].
    Sorensen K; Nielsen J
    Ugeskr Laeger; 1977 Oct; 139(43):2559-61. PubMed ID: 337609
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome.
    Copeland KC
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1278-82. PubMed ID: 3372687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
    Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
    J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone.
    Bertelloni S; Cinquanta L; Baroncelli GI; Simi P; Rossi S; Saggese G
    Horm Res; 2000; 53(2):72-6. PubMed ID: 10971092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
    Bergmann P; Valsamis J; Van Perborgh J; De Schepper J; Van Vliet G
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.